000 01625 a2200493 4500
005 20250517194950.0
264 0 _c20180416
008 201804s 0 0 eng d
022 _a0946-1965
024 7 _a10.5414/CP203121
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aHessmann, Philipp
245 0 0 _aAntidepressant medication in a German cohort of patients with Alzheimer's disease
.
_h[electronic resource]
260 _bInternational journal of clinical pharmacology and therapeutics
_cMar 2018
300 _a101-112 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAged
650 0 4 _aAged, 80 and over
650 0 4 _aAlzheimer Disease
_xdrug therapy
650 0 4 _aAntidepressive Agents
_xadverse effects
650 0 4 _aCognition
_xdrug effects
650 0 4 _aCognitive Dysfunction
_xdrug therapy
650 0 4 _aCohort Studies
650 0 4 _aCross-Sectional Studies
650 0 4 _aFemale
650 0 4 _aGermany
650 0 4 _aHumans
650 0 4 _aLogistic Models
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aQuality of Life
650 0 4 _aSeverity of Illness Index
700 1 _aDodel, Richard
700 1 _aBaum, Erika
700 1 _aMüller, Matthias J
700 1 _aPaschke, Greta
700 1 _aKis, Bernhard
700 1 _aZeidler, Jan
700 1 _aKlora, Mike
700 1 _aReese, Jens-Peter
700 1 _aBalzer-Geldsetzer, Monika
773 0 _tInternational journal of clinical pharmacology and therapeutics
_gvol. 56
_gno. 3
_gp. 101-112
856 4 0 _uhttps://doi.org/10.5414/CP203121
_zAvailable from publisher's website
999 _c27995730
_d27995730